How many insider trades does FilingIQ track for FGEN?

FilingIQ tracks 1,595 Form 4 insider transactions for FGEN (FIBROGEN INC), covering filings from Nov 19, 2014 onwards. 0 of those were filed in the last 90 days.

Are FGEN insiders net buyers or net sellers?

Across the full Form 4 history for FGEN, 11 transactions (1%) were open-market purchases and 827 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FGEN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is FGEN in?

FIBROGEN INC (FGEN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $29.77M.

FGEN insider trading

Healthcare

FIBROGEN INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

1,595

Last 90 days

Buys / sells

1% / 52%

Market cap

$29.77M

About FIBROGEN INC

Kyntra Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. Its pipeline products include FG-3165 and FG-3175, an anti-GAL-9 antibody for treatment of solid tumors. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. The company was formerly known as FibroGen, Inc. and change its name to Kyntra Bio, Inc. in January 2026. Kyntra Bio, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Company website: www.kyntrabio.com

FGEN insider activity at a glance

FilingIQ has scored 1,595 insider transactions for FGEN since Nov 19, 2014. The most recent filing in our index is dated Dec 6, 2025.

Across the full history, 11 open-market purchases and 827 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FGEN insider trades is 59.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FGEN trades on FilingIQ Raw filings on SEC EDGAR

Latest FGEN Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for FGEN?: FilingIQ tracks 1,595 Form 4 insider transactions for FGEN (FIBROGEN INC), covering filings from Nov 19, 2014 onwards. 0 of those were filed in the last 90 days.
Are FGEN insiders net buyers or net sellers?: Across the full Form 4 history for FGEN, 11 transactions (1%) were open-market purchases and 827 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FGEN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is FGEN in?: FIBROGEN INC (FGEN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $29.77M.

Methodology & sources

Every FGEN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.